Clinical implications of intratumor heterogeneity: challenges and opportunities
S Ramón y Cajal, M Sesé, C Capdevila… - Journal of Molecular …, 2020 - Springer
In this review, we highlight the role of intratumoral heterogeneity, focusing on the clinical and
biological ramifications this phenomenon poses. Intratumoral heterogeneity arises through …
biological ramifications this phenomenon poses. Intratumoral heterogeneity arises through …
The neural addiction of cancer
C Magnon, H Hondermarck - Nature Reviews Cancer, 2023 - nature.com
The recently uncovered key role of the peripheral and central nervous systems in controlling
tumorigenesis and metastasis has opened a new area of research to identify innovative …
tumorigenesis and metastasis has opened a new area of research to identify innovative …
[HTML][HTML] Gut microbes promote colonic serotonin production through an effect of short-chain fatty acids on enterochromaffin cells
CS Reigstad, CE Salmonson, JF Rainey III… - The FASEB …, 2014 - pmc.ncbi.nlm.nih.gov
Gut microbiota alterations have been described in several diseases with altered
gastrointestinal (GI) motility, and awareness is increasing regarding the role of the gut …
gastrointestinal (GI) motility, and awareness is increasing regarding the role of the gut …
Ghrelin: much more than a hunger hormone
In addition to ghrelin's effects on appetite and adiposity, ghrelin signalling also plays crucial
roles in glucose and energy homeostasis, cardioprotection, muscle atrophy and bone …
roles in glucose and energy homeostasis, cardioprotection, muscle atrophy and bone …
Is ghrelin synthesized in the central nervous system?
A Cabral, EJ Lopez Soto, J Epelbaum… - International journal of …, 2017 - mdpi.com
Ghrelin is an octanoylated peptide that acts via its specific receptor, the growth hormone
secretagogue receptor type 1a (GHSR-1a), and regulates a vast variety of physiological …
secretagogue receptor type 1a (GHSR-1a), and regulates a vast variety of physiological …
Ghrelin as a promising therapeutic option for cancer cachexia
MN Khatib, A Gaidhane, S Gaidhane… - Cellular Physiology and …, 2018 - karger.com
Cachexia is a devastating complication of cancer and an important cause of morbidity and
mortality and can have a great effect on quality of life, and sense of self-esteem …
mortality and can have a great effect on quality of life, and sense of self-esteem …
Novel and conventional receptors for ghrelin, desacyl-ghrelin, and pharmacologically related compounds
B Callaghan, JB Furness - Pharmacological reviews, 2014 - ASPET
The only molecularly identified ghrelin receptor is the growth hormone secretagogue
receptor GHSR1a. Its natural ligand, ghrelin, is an acylated peptide whose unacylated …
receptor GHSR1a. Its natural ligand, ghrelin, is an acylated peptide whose unacylated …
Truncated somatostatin receptor variant sst5TMD4 confers aggressive features (proliferation, invasion and reduced octreotide response) to somatotropinomas
RM Luque, A Ibáñez-Costa, LV Neto, GF Taboada… - Cancer Letters, 2015 - Elsevier
The GH/IGF1 response of somatotropinomas to somatostatin analogues (SSA) is associated
with their pattern of somatostatin receptor (sst1-sst5) expression. Recently, we demonstrated …
with their pattern of somatostatin receptor (sst1-sst5) expression. Recently, we demonstrated …
The ghrelin axis—does it have an appetite for cancer progression?
Ghrelin, the endogenous ligand for the GH secretagogue receptor (GHSR), is a peptide
hormone with diverse physiological roles. Ghrelin regulates GH release, appetite and …
hormone with diverse physiological roles. Ghrelin regulates GH release, appetite and …
Dysregulation of splicing variants and spliceosome components in breast cancer
MD Gahete, N Herman-Sanchez… - Endocrine-Related …, 2022 - erc.bioscientifica.com
The dysregulation of the splicing process has emerged as a novel hallmark of metabolic and
tumor pathologies. In breast cancer (BCa), which represents the most diagnosed cancer …
tumor pathologies. In breast cancer (BCa), which represents the most diagnosed cancer …